anti-MERSC-CoV antibody product blog
Tags: Antibody; Polyclonal Antibody; MERSC-CoV; anti-MERSC-CoV antibody;
The MERSC-CoV n/a (Catalog #MBS448115) is an Antibody produced from Goat and is intended for research purposes only. The product is available for immediate purchase. The MERSC-CoV Spike Protein Polyclonal Antibody reacts with Middle East respiratory Syndrome coronavirus and may cross-react with other species as described in the data sheet. MyBioSource\'s MERSC-CoV can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunofluorescence (IF), Immunuhistochemistry (paraffin) (IHC-P), Immunohistochemistry (frozen) (IHC-F).Western blot: 1:250-1:2,000. Researchers should empirically determine the suitability of the MERSC-CoV n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the MERSC-CoV Spike Protein Polyclonal Antibody with the following immunoassay(s):
Reactivity Data
Testing Data
Goat polyclonal to Spike protein of Middle East respiratory Syndrome coronavirus. Coronaviruses access host cells by membrane fusion, a process mediated by specific fusion or "spike" proteins on the virion, often activated by cellular proteases.
Immunogen: Recombinant peptide derived from within residues 381-505 aa (Spike receptor binding domain) of Spike protein from Middle East respiratory syndrome coronavirus produced in E Coli. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing MERSC-CoV are readily searchable from our website. Different antibodies against the same target such as MERSC-CoV may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.